Related Experiment Videos
Immunosuppression in nerve allografting: is it desirable?
A D Ansselin1, J D Pollard, D F Davey
1Microsurgery Research Centre, NSW, Australia.
Journal of the Neurological Sciences
|October 1, 1992
Summary
Low-dose cyclosporin A (CsA) did not induce tolerance in immunologically incompatible sciatic nerve grafts in rats. CsA may also negatively impact nerve function, warranting caution in its combined use with nerve allografts.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Nerve allografts are used to repair severed nerves.
- Immunological rejection limits allograft success.
- Cyclosporin A (CsA) is an immunosuppressant.
Purpose of the Study:
- To investigate if low-dose CsA can induce tolerance to sciatic nerve allografts.
- To assess the impact of CsA on nerve regeneration and function.
Main Methods:
- Immunologically incompatible sciatic nerve allografts were transplanted into Wistar rats.
- Animals received daily low-dose CsA (5 mg/kg or 10 mg/kg) for 20 weeks, followed by withdrawal.
- Functional recovery was assessed via behavioral, electrophysiological, and histological analyses.
Main Results:
- All animals showed some nerve regeneration, irrespective of CsA treatment.
- Low-dose CsA failed to prevent allograft rejection and disruption.
- Limited reinnervation and poor functional recovery were observed in CsA-treated groups.
- CsA administration correlated with decreased electromyograph amplitudes in both experimental and control nerves.
- Axonal regeneration outside graft fascicles indicated incomplete integration.
Conclusions:
- Low-dose CsA is insufficient to induce tolerance in rat sciatic nerve allografts.
- CsA may exert neurotoxic effects, impairing nerve function even at low doses.
- Caution is advised when combining nerve allografts with CsA immunosuppression pending further neurotoxicity investigation.